Page last updated: 2024-09-05

lixivaptan and opc 21268

lixivaptan has been researched along with opc 21268 in 1 studies

Compound Research Comparison

Studies
(lixivaptan)
Trials
(lixivaptan)
Recent Studies (post-2010)
(lixivaptan)
Studies
(opc 21268)
Trials
(opc 21268)
Recent Studies (post-2010) (opc 21268)
80102613336

Protein Interaction Comparison

ProteinTaxonomylixivaptan (IC50)opc 21268 (IC50)
Vasopressin V1a receptorRattus norvegicus (Norway rat)0.44

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G1

Reviews

1 review(s) available for lixivaptan and opc 21268

ArticleYear
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
    Clinical science (London, England : 1979), 2003, Volume: 105, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins

2003